TSC
Two Seas Capital’s Esperion Therapeutics ESPR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.8M | Buy |
9,954,975
+3,024,104
| +44% | +$2.98M | 0.16% | 20 |
|
|
2025
Q1 | $9.98M | Buy |
6,930,871
+700,000
| +11% | +$1.01M | 0.31% | 14 |
|
|
2024
Q4 | $13.7M | Sell |
6,230,871
-353,407
| -5% | -$777K | 1.18% | 12 |
|
|
2024
Q3 | $10.9M | Buy |
6,584,278
+848,618
| +15% | +$1.4M | 1.76% | 11 |
|
|
2024
Q2 | $12.7M | Buy |
5,735,660
+1,570,003
| +38% | +$3.49M | 2.07% | 11 |
|
|
2024
Q1 | $11.2M | Sell |
4,165,657
-3,520,463
| -46% | -$9.43M | 2.19% | 9 |
|
|
2023
Q4 | $23M | Buy |
7,686,120
+13,950
| +0.2% | +$41.7K | 5.61% | 3 |
|
|
2023
Q3 | $7.52M | Buy |
7,672,170
+4,730,298
| +161% | +$4.64M | 1.51% | 8 |
|
|
2023
Q2 | $4.09M | Buy |
+2,941,872
| New | +$4.09M | 0.89% | 6 |
|